The forecasted sold production of blood-grouping reagents in Germany shows moderate, continuous growth from 2024 to 2028, increasing from 774.24 million Euros to 824.89 million Euros. When evaluating the year-on-year percentage variations, there's a consistent upward trend with modest increases each year, averaging around 1.5% annually. If we look historically, the value in 2023 stood slightly lower, setting the stage for this growth trajectory observed in the following years.
Looking forward, important trends to watch include advancements in medical diagnostics, changes in healthcare regulations within the EU, and potential disruptions in the global supply chain that may influence production costs or demand dynamics.
